Skip to content
STAT News1 min read

STAT+: AI drug developer Insilico Medicine and...

Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks
Read original on statnews.com
0
0

Comment

Sign in to join the discussion.

Loading comments…

Related

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Liked this? Start your own feed.

0
0